{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:01:05Z","timestamp":1790128865308,"version":"4.0.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010622","name":"Eye Disease Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canadian Foundation for Innovation"},{"DOI":"10.13039\/501100004889","name":"Fondation du CHU de Qu\u00e9bec","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004889","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015115","name":"Fondation de l\u2019Universit\u00e9 Laval","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015115","id-type":"DOI","asserted-by":"crossref"}]},{"name":"FRQS Vision Health Research Network"},{"name":"Fondation d\u2019ophtalmologie, recherche et d\u00e9veloppement"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s10585-018-9894-x","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T15:23:59Z","timestamp":1524669839000},"page":"123-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Expression of the serotonin receptor 2B in uveal melanoma and effects of an antagonist on cell lines"],"prefix":"10.1007","volume":"35","author":[{"given":"Cindy","family":"Weidmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"B\u00e9rub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Piquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"de la Fouchardi\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-0657","authenticated-orcid":false,"given":"Solange","family":"Landreville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,25]]},"reference":[{"issue":"5","key":"9894_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2217\/14796694.4.5.629","volume":"4","author":"S Landreville","year":"2008","unstructured":"Landreville S, Agapova OA, Harbour JW (2008) Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol 4(5):629\u2013636. https:\/\/doi.org\/10.2217\/14796694.4.5.629","journal-title":"Future Oncol"},{"issue":"1","key":"9894_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","volume":"18","author":"AD Singh","year":"2005","unstructured":"Singh AD, Bergman L, Seregard S (2005) Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 18(1):75\u201384. https:\/\/doi.org\/10.1016\/j.ohc.2004.07.002 viii.","journal-title":"Ophthalmol Clin North Am"},{"issue":"11","key":"9894_CR3","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, Makitie T, Kivela T (2003) Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 44(11):4651\u20134659","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"9894_CR4","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","volume":"123","author":"M Diener-West","year":"2005","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi I, Jampol LM, Kirkwood JM, Koh WJ, Robertson DM, Shaw JM, Straatsma BR, Thoma J (2005) Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: collaborative ocular melanoma study group report No. 26. Arch Ophthalmol 123(12):1639\u20131643. https:\/\/doi.org\/10.1001\/archopht.123.12.1639","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"9894_CR5","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/1097-0142(19901001)66:7<1596::AID-CNCR2820660726>3.0.CO;2-6","volume":"66","author":"JJ Augsburger","year":"1990","unstructured":"Augsburger JJ, Gamel JW (1990) Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 66(7):1596\u20131600","journal-title":"Cancer"},{"issue":"6","key":"9894_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0002-9394(98)00040-3","volume":"125","author":"DM Albert","year":"1998","unstructured":"Albert DM, Diener-West M, Robinson NL, Grossniklaus HE, Green WR, Vine AK, Willis J, Frueh B, Kurtz RM, Elner S, Johnson MW (1998) Histopathologic characteristics of uveal melanomas in eyes enucleated from the Collaborative Ocular Melanoma Study. COMS report no. 6. Am J Ophthalmol 125(6):745\u2013766","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"9894_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2","volume":"19","author":"K Sisley","year":"1997","unstructured":"Sisley K, Rennie IG, Parsons MA, Jacques R, Hammond DW, Bell SM, Potter AM, Rees RC (1997) Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosom Cancer 19(1):22\u201328","journal-title":"Genes Chromosom Cancer"},{"issue":"6009","key":"9894_CR8","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330(6009):1410\u20131413. https:\/\/doi.org\/10.1126\/science.1194472","journal-title":"Science"},{"key":"9894_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618","author":"JW Harbour","year":"2013","unstructured":"Harbour JW, Chen R (2013) The Decisiondx-UM gene expression profile test provides risk stratification and individualized patient care in uveal melanoma. PLoS Curr. https:\/\/doi.org\/10.1371\/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618","journal-title":"PLoS Curr"},{"issue":"4","key":"9894_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2353\/jmoldx.2010.090220","volume":"12","author":"MD Onken","year":"2010","unstructured":"Onken MD, Worley LA, Tuscan MD, Harbour JW (2010) An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn 12(4):461\u2013468. https:\/\/doi.org\/10.2353\/jmoldx.2010.090220","journal-title":"J Mol Diagn"},{"issue":"9","key":"9894_CR11","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1242\/dev.124.9.1745","volume":"124","author":"DS Choi","year":"1997","unstructured":"Choi DS, Ward SJ, Messaddeq N, Launay JM, Maroteaux L (1997) 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124(9):1745\u20131755","journal-title":"Development"},{"issue":"2\u20133","key":"9894_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0163-7258(01)00169-3","volume":"92","author":"JR Raymond","year":"2001","unstructured":"Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN (2001) Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther 92(2\u20133):179\u2013212","journal-title":"Pharmacol Ther"},{"issue":"6","key":"9894_CR13","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1074\/jbc.271.6.3141","volume":"271","author":"JM Launay","year":"1996","unstructured":"Launay JM, Birraux G, Bondoux D, Callebert J, Choi DS, Loric S, Maroteaux L (1996) Ras involvement in signal transduction by the serotonin 5-HT2B receptor. J Biol Chem 271(6):3141\u20133147","journal-title":"J Biol Chem"},{"issue":"6","key":"9894_CR14","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1073\/pnas.050282397","volume":"97","author":"CG Nebigil","year":"2000","unstructured":"Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L (2000) 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci USA 97(6):2591\u20132596. https:\/\/doi.org\/10.1073\/pnas.050282397","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"9894_CR15","doi-asserted-by":"publisher","first-page":"5230","DOI":"10.1167\/iovs.08-2145","volume":"49","author":"MD Onken","year":"2008","unstructured":"Onken MD, Worley LA, Long MD, Duan S, Council ML, Bowcock AM, Harbour JW (2008) Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest Ophthalmol Vis Sci 49(12):5230\u20135234. https:\/\/doi.org\/10.1167\/iovs.08-2145","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7229","key":"9894_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Raamsdonk Van","year":"2009","unstructured":"Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O\u2019Brien JM, Simpson EM, Barsh GS, Bastian BC (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457(7229):599\u2013602. https:\/\/doi.org\/10.1038\/nature07586","journal-title":"Nature"},{"issue":"23","key":"9894_CR17","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Raamsdonk Van","year":"2010","unstructured":"Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O\u2019Brien J, Bastian BC (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363(23):2191\u20132199. https:\/\/doi.org\/10.1056\/NEJMoa1000584","journal-title":"N Engl J Med"},{"issue":"2","key":"9894_CR18","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0169-328X(03)00173-6","volume":"115","author":"S Lucchini De","year":"2003","unstructured":"De Lucchini S, Ori M, Nardini M, Marracci S, Nardi I (2003) Expression of 5-HT2B and 5-HT2C receptor genes is associated with proliferative regions of Xenopus developing brain and eye. Brain Res Mol Brain Res 115(2):196\u2013201","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"9894_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.eururo.2005.02.006","volume":"47","author":"N Dizeyi","year":"2005","unstructured":"Dizeyi N, Bjartell A, Hedlund P, Tasken KA, Gadaleanu V, Abrahamsson PA (2005) Expression of serotonin receptors 2B and 4 in human prostate cancer tissue and effects of their antagonists on prostate cancer cell lines. Eur Urol 47(6):895\u2013900. https:\/\/doi.org\/10.1016\/j.eururo.2005.02.006","journal-title":"Eur Urol"},{"issue":"2","key":"9894_CR20","first-page":"363","volume":"33","author":"PK Kopparapu","year":"2013","unstructured":"Kopparapu PK, Tinzl M, Anagnostaki L, Persson JL, Dizeyi N (2013) Expression and localization of serotonin receptors in human breast cancer. Anticancer Res 33(2):363\u2013370","journal-title":"Anticancer Res"},{"issue":"12","key":"9894_CR21","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1002\/cncr.25049","volume":"116","author":"B Svejda","year":"2010","unstructured":"Svejda B, Kidd M, Giovinazzo F, Eltawil K, Gustafsson BI, Pfragner R, Modlin IM (2010) The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment. Cancer 116(12):2902\u20132912. https:\/\/doi.org\/10.1002\/cncr.25049","journal-title":"Cancer"},{"issue":"4","key":"9894_CR22","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/hep.23441","volume":"51","author":"C Soll","year":"2010","unstructured":"Soll C, Jang JH, Riener MO, Moritz W, Wild PJ, Graf R, Clavien PA (2010) Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology 51(4):1244\u20131254. https:\/\/doi.org\/10.1002\/hep.23441","journal-title":"Hepatology"},{"issue":"1","key":"9894_CR23","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/j.gastro.2017.03.008","volume":"153","author":"SH Jiang","year":"2017","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, Wang YH, Yang MW, Fu XL, Zhang XX, Li Q, Pang XF, Huo YM, Li J, Zhang JF, Lee HY, Lee SJ, Qin WX, Gu JR, Sun YW, Zhang ZG (2017) Increased serotonin signaling contributes to the warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology 153(1):277\u2013291. https:\/\/doi.org\/10.1053\/j.gastro.2017.03.008","journal-title":"Gastroenterology"},{"issue":"4","key":"9894_CR24","first-page":"1361","volume":"32","author":"R Henriksen","year":"2012","unstructured":"Henriksen R, Dizeyi N, Abrahamsson PA (2012) Expression of serotonin receptors 5-HT1A, 5-HT1B, 5-HT2B and 5-HT4 in ovary and in ovarian tumours. Anticancer Res 32(4):1361\u20131366","journal-title":"Anticancer Res"},{"issue":"4","key":"9894_CR25","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1755-148X.2011.00869.x","volume":"24","author":"S Landreville","year":"2011","unstructured":"Landreville S, Vigneault F, Bergeron MA, Leclerc S, Gaudreault M, Morcos M, Mouriaux F, Salesse C, Guerin SL (2011) Suppression of alpha5 gene expression is closely related to the tumorigenic properties of uveal melanoma cell lines. Pigm Cell Melanoma Res 24(4):643\u2013655. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00869.x","journal-title":"Pigm Cell Melanoma Res"},{"issue":"13","key":"9894_CR26","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1167\/iovs.16-19317","volume":"57","author":"F Mouriaux","year":"2016","unstructured":"Mouriaux F, Zaniolo K, Bergeron MA, Weidmann C, De La Fouchardiere A, Fournier F, Droit A, Morcos MW, Landreville S, Guerin SL (2016) Effects of long-term serial passaging on the characteristics and properties of cell lines derived from uveal melanoma primary tumors. Invest Ophthalmol Vis Sci 57(13):5288\u20135301. https:\/\/doi.org\/10.1167\/iovs.16-19317","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9894_CR27","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1167\/iovs.13-13345","volume":"55","author":"F Mouriaux","year":"2014","unstructured":"Mouriaux F, Sanschagrin F, Diorio C, Landreville S, Comoz F, Petit E, Bernaudin M, Rousseau AP, Bergeron D, Morcos M (2014) Increased HIF-1alpha expression correlates with cell proliferation and vascular markers CD31 and VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci 55(3):1277\u20131283. https:\/\/doi.org\/10.1167\/iovs.13-13345","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9894_CR28","first-page":"1813","volume":"18","author":"MA Bergeron","year":"2012","unstructured":"Bergeron MA, Champagne S, Gaudreault M, Deschambeault A, Landreville S (2012) Repression of genes involved in melanocyte differentiation in uveal melanoma. Mol Vis 18:1813\u20131822","journal-title":"Mol Vis"},{"issue":"7","key":"9894_CR29","first-page":"2210","volume":"34","author":"DN Hu","year":"1993","unstructured":"Hu DN, McCormick SA, Ritch R, Pelton-Henrion K (1993) Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci 34(7):2210\u20132219","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"9894_CR30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/cge.12472","volume":"88","author":"A Fouchardiere de la","year":"2015","unstructured":"de la Fouchardiere A, Cabaret O, Savin L, Combemale P, Schvartz H, Penet C, Bonadona V, Soufir N, Bressac-de Paillerets B (2015) Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet 88(3):273\u2013277. https:\/\/doi.org\/10.1111\/cge.12472","journal-title":"Clin Genet"},{"issue":"3","key":"9894_CR31","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1755-148X.2011.00841.x","volume":"24","author":"S Landreville","year":"2011","unstructured":"Landreville S, Agapova OA, Kneass ZT, Salesse C, Harbour JW (2011) ABCB1 identifies a subpopulation of uveal melanoma cells with high metastatic propensity. Pigm Cell Melanoma Res 24(3):430\u2013437. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00841.x","journal-title":"Pigm Cell Melanoma Res"},{"key":"9894_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-1-4939-2550-6_27","volume":"1295","author":"JE Gilda","year":"2015","unstructured":"Gilda JE, Gomes AV (2015) Western blotting using in-gel protein labeling as a normalization control: stain-free technology. Methods Mol Biol 1295:381\u2013391. https:\/\/doi.org\/10.1007\/978-1-4939-2550-6_27","journal-title":"Methods Mol Biol"},{"key":"9894_CR33","doi-asserted-by":"publisher","first-page":"50948","DOI":"10.3791\/50948","volume":"82","author":"A Posch","year":"2013","unstructured":"Posch A, Kohn J, Oh K, Hammond M, Liu N (2013) V3 stain-free workflow for a practical, convenient, and reliable total protein loading control in western blotting. J Vis Exp 82:50948. https:\/\/doi.org\/10.3791\/50948","journal-title":"J Vis Exp"},{"issue":"7","key":"9894_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3727\/095535491820873191","volume":"3","author":"AH Cory","year":"1991","unstructured":"Cory AH, Owen TC, Barltrop JA, Cory JG (1991) Use of an aqueous soluble tetrazolium\/formazan assay for cell growth assays in culture. Cancer Commun 3(7):207\u2013212","journal-title":"Cancer Commun"},{"issue":"2","key":"9894_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1124\/jpet.109.165001","volume":"334","author":"SL Porvasnik","year":"2010","unstructured":"Porvasnik SL, Germain S, Embury J, Gannon KS, Jacques V, Murray J, Byrne BJ, Shacham S, Al-Mousily F (2010) PRX-08066, a novel 5-hydroxytryptamine receptor 2B antagonist, reduces monocrotaline-induced pulmonary arterial hypertension and right ventricular hypertrophy in rats. J Pharmacol Exp Ther 334(2):364\u2013372. https:\/\/doi.org\/10.1124\/jpet.109.165001","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"9894_CR36","doi-asserted-by":"publisher","first-page":"e0148657","DOI":"10.1371\/journal.pone.0148657","volume":"11","author":"JD West","year":"2016","unstructured":"West JD, Carrier EJ, Bloodworth NC, Schroer AK, Chen P, Ryzhova LM, Gladson S, Shay S, Hutcheson JD, Merryman WD (2016) Serotonin 2B receptor antagonism prevents heritable pulmonary arterial hypertension. PLoS ONE 11(2):e0148657. https:\/\/doi.org\/10.1371\/journal.pone.0148657","journal-title":"PLoS ONE"},{"issue":"10","key":"9894_CR37","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/nm764","volume":"8","author":"JM Launay","year":"2002","unstructured":"Launay JM, Herve P, Peoc\u2019h K, Tournois C, Callebert J, Nebigil CG, Etienne N, Drouet L, Humbert M, Simonneau G, Maroteaux L (2002) Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 8(10):1129\u20131135. https:\/\/doi.org\/10.1038\/nm764","journal-title":"Nat Med"},{"issue":"3","key":"9894_CR38","first-page":"419","volume":"2","author":"HA Mucke","year":"2001","unstructured":"Mucke HA (2001) Mt-500 (Pozen). Curr Opin Invest Drugs 2(3):419\u2013421","journal-title":"Curr Opin Invest Drugs"},{"issue":"1","key":"9894_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1046\/j.1468-2982.1997.1701003.x","volume":"17","author":"A Panconesi","year":"1997","unstructured":"Panconesi A, Sicuteri R (1997) Headache induced by serotonergic agonists\u2013a key to the interpretation of migraine pathogenesis? Cephalalgia 17(1):3\u201314","journal-title":"Cephalalgia"},{"issue":"5","key":"9894_CR40","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/sj.bjp.0704571","volume":"135","author":"RA Borman","year":"2002","unstructured":"Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS (2002) 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro. Br J Pharmacol 135(5):1144\u20131151. https:\/\/doi.org\/10.1038\/sj.bjp.0704571","journal-title":"Br J Pharmacol"},{"issue":"6","key":"9894_CR41","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.coph.2008.07.003","volume":"8","author":"R Spiller","year":"2008","unstructured":"Spiller R (2008) Serotonergic agents and the irritable bowel syndrome: what goes wrong? Curr Opin Pharmacol 8(6):709\u2013714. https:\/\/doi.org\/10.1016\/j.coph.2008.07.003","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"9894_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35043102","volume":"1","author":"JR Masters","year":"2000","unstructured":"Masters JR (2000) Human cancer cell lines: fact and fantasy. Nat Rev Mol Cell Biol 1(3):233\u2013236. https:\/\/doi.org\/10.1038\/35043102","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"9894_CR43","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ijc.10893","volume":"103","author":"E Kielhorn","year":"2003","unstructured":"Kielhorn E, Provost E, Olsen D, D\u2019Aquila TG, Smith BL, Camp RL, Rimm DL (2003) Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer 103(5):652\u2013656. https:\/\/doi.org\/10.1002\/ijc.10893","journal-title":"Int J Cancer"},{"issue":"6","key":"9894_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/CMR.0b013e3282f1d302","volume":"17","author":"W Zuidervaart","year":"2007","unstructured":"Zuidervaart W, Pavey S, van Nieuwpoort FA, Packer L, Out C, Maat W, Jager MJ, Gruis NA, Hayward NK (2007) Expression of Wnt5a and its downstream effector beta-catenin in uveal melanoma. Melanoma Res 17(6):380\u2013386. https:\/\/doi.org\/10.1097\/CMR.0b013e3282f1d302","journal-title":"Melanoma Res"},{"issue":"6","key":"9894_CR45","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ccell.2016.04.015","volume":"29","author":"JH Yoo","year":"2016","unstructured":"Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, Rogers A, Zhu W, Richards JR, Winter JM, Zhu J, Dunn C, Bajji A, Shenderovich M, Mueller AL, Woodman SE, Harbour JW, Thomas KR, Odelberg SJ, Ostanin K, Li DY (2016) ARF6 Is an actionable node that orchestrates oncogenic GNAQ signaling in uveal melanoma. Cancer Cell 29(6):889\u2013904. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.015","journal-title":"Cancer Cell"},{"issue":"8","key":"9894_CR46","doi-asserted-by":"publisher","first-page":"e23429","DOI":"10.1371\/journal.pone.0023429","volume":"6","author":"T Sinnberg","year":"2011","unstructured":"Sinnberg T, Menzel M, Ewerth D, Sauer B, Schwarz M, Schaller M, Garbe C, Schittek B (2011) Beta-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS ONE 6(8):e23429. https:\/\/doi.org\/10.1371\/journal.pone.0023429","journal-title":"PLoS ONE"},{"issue":"21","key":"9894_CR47","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/sj.onc.1203480","volume":"19","author":"DE Levy","year":"2000","unstructured":"Levy DE, Gilliland DG (2000) Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene 19(21):2505\u20132510. https:\/\/doi.org\/10.1038\/sj.onc.1203480","journal-title":"Oncogene"},{"issue":"18","key":"9894_CR48","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.cub.2005.08.036","volume":"15","author":"C Wellbrock","year":"2005","unstructured":"Wellbrock C, Weisser C, Hassel JC, Fischer P, Becker J, Vetter CS, Behrmann I, Kortylewski M, Heinrich PC, Schartl M (2005) STAT5 contributes to interferon resistance of melanoma cells. Curr Biol 15(18):1629\u20131639. https:\/\/doi.org\/10.1016\/j.cub.2005.08.036","journal-title":"Curr Biol"},{"issue":"10","key":"9894_CR49","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1038\/sj.jid.5700385","volume":"126","author":"A Mirmohammadsadegh","year":"2006","unstructured":"Mirmohammadsadegh A, Hassan M, Bardenheuer W, Marini A, Gustrau A, Nambiar S, Tannapfel A, Bojar H, Ruzicka T, Hengge UR (2006) STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases. J Invest Dermatol 126(10):2272\u20132280. https:\/\/doi.org\/10.1038\/sj.jid.5700385","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9894_CR50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/stem.1843","volume":"33","author":"KE Williams","year":"2015","unstructured":"Williams KE, Bundred NJ, Landberg G, Clarke RB, Farnie G (2015) Focal adhesion kinase and Wnt signaling regulate human ductal carcinoma in situ stem cell activity and response to radiotherapy. Stem Cells 33(2):327\u2013341. https:\/\/doi.org\/10.1002\/stem.1843","journal-title":"Stem Cells"},{"issue":"21","key":"9894_CR51","doi-asserted-by":"publisher","first-page":"18573","DOI":"10.1074\/jbc.M110.200717","volume":"286","author":"H Fan","year":"2011","unstructured":"Fan H, Guan JL (2011) Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity. J Biol Chem 286(21):18573\u201318582. https:\/\/doi.org\/10.1074\/jbc.M110.200717","journal-title":"J Biol Chem"},{"issue":"12","key":"9894_CR52","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/sj.onc.1210819","volume":"27","author":"S Roelle","year":"2008","unstructured":"Roelle S, Grosse R, Buech T, Chubanov V, Gudermann T (2008) Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 27(12):1737\u20131748. https:\/\/doi.org\/10.1038\/sj.onc.1210819","journal-title":"Oncogene"},{"key":"9894_CR53","doi-asserted-by":"publisher","first-page":"31963","DOI":"10.1038\/srep31963","volume":"6","author":"B Fu","year":"2016","unstructured":"Fu B, Meng W, Zhao H, Zhang B, Tang H, Zou Y, Yao J, Li H, Zhang T (2016) GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5. Sci Rep 6:31963. https:\/\/doi.org\/10.1038\/srep31963","journal-title":"Sci Rep"},{"issue":"26","key":"9894_CR54","doi-asserted-by":"publisher","first-page":"22214","DOI":"10.18632\/oncotarget.4257","volume":"6","author":"M Selitrennik","year":"2015","unstructured":"Selitrennik M, Lev S (2015) PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop. Oncotarget 6(26):22214\u201322226. https:\/\/doi.org\/10.18632\/oncotarget.4257","journal-title":"Oncotarget"},{"issue":"11","key":"9894_CR55","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1093\/carcin\/bgn203","volume":"29","author":"CK Sun","year":"2008","unstructured":"Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST (2008) Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src\/ERK activation. Carcinogenesis 29(11):2096\u20132105. https:\/\/doi.org\/10.1093\/carcin\/bgn203","journal-title":"Carcinogenesis"},{"issue":"3","key":"9894_CR56","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.lungcan.2008.05.008","volume":"62","author":"S Zhang","year":"2008","unstructured":"Zhang S, Qiu X, Gu Y, Wang E (2008) Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. Lung Cancer 62(3):295\u2013301. https:\/\/doi.org\/10.1016\/j.lungcan.2008.05.008","journal-title":"Lung Cancer"},{"issue":"2","key":"9894_CR57","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molonc.2015.09.008","volume":"10","author":"S Fatima","year":"2016","unstructured":"Fatima S, Shi X, Lin Z, Chen GQ, Pan XH, Wu JC, Ho JW, Lee NP, Gao H, Zhang G, Lu A, Bian ZX (2016) 5-Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing beta-catenin. Mol Oncol 10(2):195\u2013212. https:\/\/doi.org\/10.1016\/j.molonc.2015.09.008","journal-title":"Mol Oncol"},{"issue":"28","key":"9894_CR58","doi-asserted-by":"publisher","first-page":"25975","DOI":"10.18632\/oncotarget.4543","volume":"6","author":"H Sui","year":"2015","unstructured":"Sui H, Xu H, Ji Q, Liu X, Zhou L, Song H, Zhou X, Xu Y, Chen Z, Cai J, Ji G, Li Q (2015) 5-hydroxytryptamine receptor (5-HT1DR) promotes colorectal cancer metastasis by regulating Axin1\/beta-catenin\/MMP-7 signaling pathway. Oncotarget 6(28):25975\u201325987. https:\/\/doi.org\/10.18632\/oncotarget.4543","journal-title":"Oncotarget"},{"issue":"1","key":"9894_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/14728222.11.1.91","volume":"11","author":"J Homsi","year":"2007","unstructured":"Homsi J, Cubitt C, Daud A (2007) The Src signaling pathway: a potential target in melanoma and other malignancies. Expert Opin Ther Targets 11(1):91\u2013100. https:\/\/doi.org\/10.1517\/14728222.11.1.91","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"9894_CR60","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1091\/mbc.e05-10-0927","volume":"17","author":"J Qi","year":"2006","unstructured":"Qi J, Wang J, Romanyuk O, Siu CH (2006) Involvement of Src family kinases in N-cadherin phosphorylation and beta-catenin dissociation during transendothelial migration of melanoma cells. Mol Biol Cell 17(3):1261\u20131272. https:\/\/doi.org\/10.1091\/mbc.E05-10-0927","journal-title":"Mol Biol Cell"},{"issue":"6600","key":"9894_CR61","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/383547a0","volume":"383","author":"I Dikic","year":"1996","unstructured":"Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J (1996) A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383(6600):547\u2013550. https:\/\/doi.org\/10.1038\/383547a0","journal-title":"Nature"},{"issue":"2","key":"9894_CR62","doi-asserted-by":"publisher","first-page":"e0149231","DOI":"10.1371\/journal.pone.0149231","volume":"11","author":"M Zhao","year":"2016","unstructured":"Zhao M, Finlay D, Zharkikh I, Vuori K (2016) Novel role of Src in priming Pyk2 phosphorylation. PLoS ONE 11(2):e0149231. https:\/\/doi.org\/10.1371\/journal.pone.0149231","journal-title":"PLoS ONE"},{"key":"9894_CR63","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.10072","author":"C Gao","year":"2015","unstructured":"Gao C, Chen G, Kuan SF, Zhang DH, Schlaepfer DD, Hu J (2015) FAK\/PYK2 promotes the Wnt\/beta-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3beta. Elife. https:\/\/doi.org\/10.7554\/eLife.10072","journal-title":"Elife"},{"issue":"22","key":"9894_CR64","doi-asserted-by":"publisher","first-page":"21129","DOI":"10.1074\/jbc.M500898200","volume":"280","author":"JD Buul van","year":"2005","unstructured":"van Buul JD, Anthony EC, Fernandez-Borja M, Burridge K, Hordijk PL (2005) Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation. J Biol Chem 280(22):21129\u201321136. https:\/\/doi.org\/10.1074\/jbc.M500898200","journal-title":"J Biol Chem"},{"issue":"20","key":"9894_CR65","doi-asserted-by":"publisher","first-page":"9948","DOI":"10.1158\/0008-5472.CAN-06-1092","volume":"66","author":"TK Lee","year":"2006","unstructured":"Lee TK, Man K, Poon RT, Lo CM, Yuen AP, Ng IO, Ng KT, Leonard W, Fan ST (2006) Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res 66(20):9948\u20139956. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1092","journal-title":"Cancer Res"},{"issue":"3","key":"9894_CR66","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.jcmgh.2017.01.002","volume":"3","author":"Q Yang","year":"2017","unstructured":"Yang Q, Yan C, Yin C, Gong Z (2017) Serotonin activated hepatic stellate cells contribute to sex disparity in hepatocellular carcinoma. Cell Mol Gastroenterol Hepatol 3(3):484\u2013499. https:\/\/doi.org\/10.1016\/j.jcmgh.2017.01.002","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"9894_CR67","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1038\/nm.2490","volume":"17","author":"MR Ebrahimkhani","year":"2011","unstructured":"Ebrahimkhani MR, Oakley F, Murphy LB, Mann J, Moles A, Perugorria MJ, Ellis E, Lakey AF, Burt AD, Douglass A, Wright MC, White SA, Jaffre F, Maroteaux L, Mann DA (2011) Stimulating healthy tissue regeneration by targeting the 5-HT(2)B receptor in chronic liver disease. Nat Med 17(12):1668\u20131673. https:\/\/doi.org\/10.1038\/nm.2490","journal-title":"Nat Med"},{"issue":"2","key":"9894_CR68","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/hep.24384","volume":"54","author":"N Kang","year":"2011","unstructured":"Kang N, Gores GJ, Shah VH (2011) Hepatic stellate cells: partners in crime for liver metastases? Hepatology 54(2):707\u2013713. https:\/\/doi.org\/10.1002\/hep.24384","journal-title":"Hepatology"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-018-9894-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-018-9894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-018-9894-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T00:23:08Z","timestamp":1661041388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-018-9894-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["9894"],"URL":"https:\/\/doi.org\/10.1007\/s10585-018-9894-x","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"17 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors disclose no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}